Drug recall · July 21, 2021
NIFEdipine EXTENDED-RELEASE TABLETS recall
Why: Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA
- Lots / codes
Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022
- Quantity
- 504 Cartons of 50 count each; 372 Cartons of 100 count each
- Company
- The Harvard Drug Group, Livonia, MI
- Distribution
- Distributed in OH and NJ
- Initiated
- July 2, 2021 · Voluntary: Firm initiated
- Classified
- July 9, 2021
- Reported
- July 21, 2021
- Ended
- December 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nifedipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.